Routine bone marrow biopsy is not necessary in the staging of patients with classical Hodgkin lymphoma in the 18F-fluoro-2-deoxyglucose positron emission tomography era

Leukemia and Lymphoma

Volumn 53, Issue 3, 2012, Pages 381-385

  Richardson, Simon E ^a   Sudak, Jagoda ^a   Warbey, Victoria ^a   Ramsay, Alan ^b   McNamara, Christopher J ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Bone marrow biopsy; FDG PET; Hodgkin lymphoma; Staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18; HEMOGLOBIN;

ADULT; AGE; AGED; ARTICLE; BONE MARROW BIOPSY; CANCER PATIENT; CANCER RELAPSE; CANCER STAGING; CLASSICAL HODGKIN LYMPHOMA; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FALSE POSITIVE RESULT; FEMALE; GENDER; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MEDICAL PRACTICE; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; RETROSPECTIVE STUDY; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BONE MARROW EXAMINATION; FALSE POSITIVE REACTIONS; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; GREAT BRITAIN; HEALTH CARE SURVEYS; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PHYSICIAN'S PRACTICE PATTERNS; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; RADIOPHARMACEUTICALS; UNNECESSARY PROCEDURES; YOUNG ADULT;

EID: 84857619761     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.616613     Document Type: Article

References (24)

1. C arbone PP, Kaplan HS, Musshoff K., et al. Report of the committee on Hodgkins disease staging classifi cation. Cancer Res. 1971;31:1860-1861.
2. L ister TA, Crowther D, Sutcliff e SB., et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkins disease: Cotswold meeting. J. Clin. Oncol. 1989;7:1630-1636. (Pubitemid 19272832)
3. F ranco V, Tripodo C, Rizzo A., et al. Bone marrow biopsy in Hodgkins lymphoma. Eur. J. Haematol. 2004;73:149-155. (Pubitemid 39062236)
4. E ngert A, Diehl V, Franklin J., et al. Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkins lymphoma: 10 years of follow-up of the GHSG HD9 study. J. Clin. Oncol. 2009;27:4548-4554.
5. Brunning RD, Bloomfi eld CD, McKenna RW., et al. Bilateral trephine bone marrow biopsies in lymphoma and other neoplastic diseases. Ann Intern Med 1975;82:365-366.
6. B ain BJ. Bone marrow biopsy morbidity and mortality: 2002 data. Clin Lab Haematol 2004;26:315-318. (Pubitemid 39440852)
7. J uweid ME, Stroobants S, Hoekstra OS., et al. Use of positron emission tomography for response assessment of lymphoma: Consensus of the imaging subcommittee of International Harmonisation Project in Lymphoma. J. Clin. Oncol. 2007;25:571-578. (Pubitemid 350002965)
8. Cheson BD, Pfi stner B, Juweid ME., et al. Revised response criteria for malignant lymphoma. J. Clin. Oncol. 2007;25:579-586. (Pubitemid 350002966)
9. E ven-Sapir E. Imaging of malignant bone involvement by morphologic, scintigraphic and hybrid modalities. J Nucl Med 2005;46:1356-1367. (Pubitemid 43733488)
10. G allamini A, Hutchings M, Rigacci L., et al. Early interim 2-[18F]fl uoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advancedstage Hodgkins lymphoma:a report from a joint Italian-Danish study. J. Clin. Oncol. 2007;25:3746-3752. (Pubitemid 47372616)
11. H utchings M, Loft A, Hansen M., et al. Positron emission tomography with or without computerized tomography in the primary staging of Hodgkins lymphoma. Haematologica 2006;91:482-489.
12. P elosi E, Penna D, Deandreis D., et al. FDG-PET in the detection of bone marrow disease in Hodgkins disease and aggressive non- Hodgkins lymphoma and its impact on clinical management. Q J Nucl Med Mol Imaging 2008;52:9-16. (Pubitemid 351351040)
13. P akos E, Fotopoulos A, Ioannidis J. 18F -FDG PET for evaluation of bone marrow infi ltration in staging of lymphoma: A meta-analysis. J Nucl Med 2005;46:958-963. (Pubitemid 43733510)
14. Shulkin B, Goodin G, McCarville M., et al. Bone and 18 fl uorodeoxyglucose positron-emission tomography/computed tomography scanning for the assessment of osseous involvement in Hodgkin lymphoma in children and young adults. Leuk Lymphoma 2009;50:1794-1802.
15. E lstrom R, Tsai D, Vergilio J., et al. Enhanced marrow 18 fl uorodeoxyglucose uptake related to myeloid hyperplasia in Hodgkins lymphoma can simulate lymphoma involvement in marrow. Clin Lymphoma 2004;5:62-64. (Pubitemid 39136445)
16. M oog F, Bangerter M, Kotzerke J., et al. 18-F-fl uorodeoxyglucosepositron emission tomography as a new approach to detect lymphomatous bone marrow. J. Clin. Oncol. 1998;16:603-609. (Pubitemid 28135606)
17. C arr R, Barrington S, Madan B., et al. Detection of lymphoma in bone marrow by whole-body positron emission tomography. Blood 1998;91:3340-3346. (Pubitemid 28193885)
18. Jerusalem G, Beguin Y, Fassotte M-F., et al. Whole-body positron emission tomography using 18 F-fl uorodeoxyglucose compared to standard procedures for staging patients with Hodgkins disease. Haematologica 2001;86:266-273. (Pubitemid 32291064)
19. Elstrom R, Guan L, Baker G., et al. Utility of FDG-PET scanning in lymphoma by WHO classifi cation. Blood 2003;101:3875-3876. (Pubitemid 36857861)
20. Munker R, Glass J, Griff eth LK., et al. Contribution of PET imaging to the initial staging and prognosis of patients with Hodgkins disease. Ann. Oncol. 2004;15:1699-1704. (Pubitemid 39562613)
21. K abickova E, Sumerauer D, Cumlivska E., et al. Comparison of 18 F-FDG-PET and standard procedures for the pretreatment staging of children and adolescents with Hodgkins disease. Eur. J. Nucl Med Mol Imaging 2006;33:1025-1031. (Pubitemid 44215668)
22. Rigacci L, Vitolo U, Nassi L., et al. Positron emission tomography in the staging of patients with Hodgkins lymphoma. A prospective multicentric study by the Intergruppo Italiano Linfomi. Ann Haematol 2007;86:897-903.
23. C erci JJ, Pracchia LF, Junior JS., et al. Positron emission tomography with 2-[18F]-fl uoro-2-deoxy-D-glucose for initial staging of Hodgkin lymphoma: A single center experience in Brazil. Clinics 2009;64: 491-498.
24. Moulin-Romsee G, Hindie E, Cuenca X., et al. 1 8 F-FDG PET/CT bone/bone marrow fi ndings in Hodgkins lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging. Eur. J. Nucl Med Mol Imaging 2010;37:1095-1105.